The Prevention of Alzheimer’s Disease by Vitamin E and Selenium trial randomized more than 7,500 older men to take vitamin E, selenium, both, or neither (just placebos) for five years.
“Preserving Your Mind” is the largest chapter of my book How Not to Age (https://nutritionfacts.org/book/how-not-to-age/). Check it out from your local public library, or listen to me read it on audiobook. (All proceeds I receive from the sales of all my books go to charity.)
Want to get a list of links to all the scientific sources used in this video? Click on Sources Cited at https://nutritionfacts.org/video/friday-favorites-can-vitamin-and-mineral-supplements-prevent-alzheimers. You’ll also find a transcript and acknowledgements for the video, my blog and speaking tour schedule, and an easy way to search (by translated language even) through our videos spanning more than 2,000 health topics.
Thanks for watching. I hope you’ll join in the evidence-based nutrition revolution! -Michael Greger, MD FACLM
Captions for this video are available in several languages; you can find yours in the video settings. View important information about our translated resources: https://nutritionfacts.org/translations-info/
This video examines whether antioxidant supplements can prevent or treat Alzheimer's disease and cognitive decline. While dietary intake of antioxidants is linked to lower risks, clinical trials generally show that supplements—including Vitamin E, C, beta-carotene, and various minerals—fail to prevent dementia or significantly improve cognitive function, with some potentially posing risks.
Oxidative stress from free radicals is one of the pathways implicated
in the development and deterioration of Alzheimer's brains,
given the evidence of excess oxidative DNA damage on autopsy.
So what about trying an antioxidant?
Vitamin E levels tend to be lower in the bloodstreams
of those with cognitive impairment or dementia, but which came first?
Maybe Alzheimer's disease led to poor eating,
rather than poor eating leading to Alzheimer's disease.
Greater vitamin E intake from foods is clearly associated
with a lower risk of developing Alzheimer's,
but greater vitamin E intake from supplements is not.
But that didn't stop researchers from including a vitamin E arm
in the largest primary prevention study of Alzheimer's disease to date.
The Prevention of Alzheimer's Disease by Vitamin E and Selenium Trial
randomized more than 7,500 older men to take vitamin E, selenium,
both or neither, just placebos, for five years.
To quote from the conclusion, neither supplement prevented dementia.
A separate long-term vitamin E supplementation trial of older women
similarly found no protection against cognitive decline.
Neither did vitamin E appear to benefit
those with mild cognitive impairment,
but the trials on Alzheimer's patients themselves started
to get more interesting.
The first trial, published in the New England Journal of Medicine,
randomized more than 150 Alzheimer's patients to vitamin E or placebo
to see if vitamin E could slow the progression of the disease.
The primary outcome was the number
of days until one of any of the following happened:
Institutionalization.
Lost the ability to perform basic activities of daily living,
or sliding into severe dementia,
where you suffer a complete loss of sense of time or place.
On first analysis, vitamin E flopped.
No significant slowing of progression.
Digging deeper, the researchers realized
that despite the random allotment,
the placebo group just by chance ended up
with patients with milder disease.
After taking that into account, the difference in outcomes
between the vitamin E and placebo groups widened substantially.
Now, this kind of unplanned post-hoc analysis is heavily frowned upon,
but the effect seemed so sizable they went ahead and published it.
In the placebo group,
the adjusted time to death or loss of independence was 440 days.
But in the vitamin E group,
after the baseline cognition was normalized,
it was 670 days, more than seven months later.
However, given the unorthodox analysis,
the scientific world waited for the study
to be replicated, and here we go.
More than 600 patients with mild to moderate Alzheimer's disease
were subsequently randomized to vitamin E supplements,
the drug memantine, both or neither, just placebos, for two years.
Although there was no slowing of cognitive decline
after adjusting for multiple comparisons,
there was a slowing of functional decline
In terms of managing daily activities like...
bathing or dressing, the vitamin
E group appeared to only suffer about 1.5 years of functional
deterioration in the two years' time,
resulting in approximately two hours less caregiver
time required each day compared to the drug group.
If those were the only two clinical vitamin E trials,
I would give vitamin E serious consideration
for those with Alzheimer's disease, but there's a third.
A six-month trial that suggested vitamin E may be detrimental
to cognition in some Alzheimer's patients.
Obviously, more research needs to be done.
In my next video, I'll cover other antioxidants
that have been put to the test,
including vitamin C, beta-carotene, centrum multivitamin,
and the minerals zinc and calcium.
Alzheimer's patients have significantly lower blood levels
of 8 out of 10 antioxidants investigated,
though of course this could just be a consequence
of demented individuals eating diets poor in fruits and vegetables.
When put to the test, the pre-advised study found no benefit
for vitamin E or selenium in terms of preventing dementia.
What about other antioxidants?
In the Harvard Physician's Health Study,
nearly 6,000 older men were randomized to beta-carotene or placebo.
No difference was found after three years, but after 11 years,
those unknowingly taking the equivalent
of a three-quarter cup of sweet potato
worth of beta-carotene a day had slightly, yet significantly better
overall cognitive performance.
A similar study followed women found no cognitive benefit
over a period of nine years.
Maybe they just didn't wait long enough.
Vitamin E and C were also tested.
Vitamin E similarly flopped throughout,
and so did vitamin C up until the last cognitive assessment
at around year 9, where the vitamin C group appeared to pull ahead.
However, two trials of a combination of vitamin C, E, and beta-carotene
together versus placebo,
one randomizing 1,500 older patients for seven years,
and another truly massive one randomizing
more than 20,000 adults for five years,
both failed to show any cognitive benefit for the antioxidant cocktail.
What about a multivitamin?
The Physician's Health Study also tested taking the daily multivitamin,
multimineral supplement Centrum Silver for 12 years.
Compared to those instead randomized to placebo,
the Centrum group experienced no cognitive benefit.
Souvenaid is a nutritional drink containing
a patented formulation of nutrients
branded as Fortisyn and that's
specifically designed to help in Alzheimer's disease.
Unfortunately, it doesn't work.
There have been three randomized controlled trials
enrolling more than 1,000 people,
and those taking Souvenaid were no less likely to develop dementia
in the first place, and probably has little or no effect
on measures of memory or other thinking skills
in both those with mild cognitive impairment or Alzheimer's disease.
In terms of specific minerals other than the failed selenium,
zinc has similarly flopped to improve overall cognition over months
or years of supplementation, and it's possible calcium supplements
could make things worse.
Cross-sectionally,
those taking calcium have more hyperintensity brain lesions
on MRI, shown here in red, denoting evidence of mini-strokes,
and longitudinally over time, women taking calcium supplements
appear to have twice the odds of developing dementia.
The Women's Health Initiative should have
been able to settle the question
once and for all.
Thousands of older women were randomized to calcium supplements
plus vitamin D or placebo for about eight years.
Thankfully, there was no difference in the risk of developing,
cognitive impairment, or dementia.
That's what was originally found for heart attack and stroke rates
before pre-existing supplement use was taken into account.
See, more than half of the women
were already taking personal calcium supplements
before entering the study and being randomized to calcium or placebo.
You can imagine how this could muddy the results.
If you just look at the women who weren't on calcium beforehand,
Starting calcium resulted in a significant increase
in the risk of cardiovascular events,
consistent with a meta-analysis of calcium trials
showing a 15% increase in heart attacks or strokes
among those randomized to calcium supplements over placebo.
Unfortunately, such a re-analysis has yet
to be performed on the dementia data.
The bottom line.
is that vitamin and mineral supplements
probably aren't going to help prevent dementia or treat it,
but there are tons of other things we can do.
Preserving Your Mind is the largest chapter of my book,
How Not to Age.
Check it out at your local public library,
or listen to me read it on audiobook.
All proceeds I receive from the sales of all my books go to charity.